Spesolimab (BI 655130) is an anti-interleukin-36 receptor antibody. It plays a crucial role in the immune system by reducing biomarkers associated with congenital Th1/Th17 and neutrophil pathways. Spesolimab can be used to study systemic pustular psoriasis, palmar and plantar impetigo (PPP), and atopic dermatitis.
Molecular Weight:
150 kDa
Purity:
0.95
CAS Number:
[2097104-58-8]
Target:
Interleukin|||IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted